Hemorrhoid Drugs Market Size

  • Report ID: 3057
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Hemorrhoid Drugs Market Size

Hemorrhoid Drugs Market size is likely to expand at significant growth rate during the forecast period i.e., between 2025-2037.

The market’s growth is influenced by the increasing cases of hemorrhoids backed by various factors such as increasing prevalence of lifestyle-based diseases, lack of physical exercise, obesity, increasing alcohol consumption, low fiber intake in diet, and growing demand for treatment options. According to the World Health Organization statistics, over 38 million children, below the age of 5 were suffering from obesity in 2019. In fact, the number of obese people globally, has tripled since 1975. Increasing number of obese people is, in turn, expected to increase the prevalence of hemorrhoid, which is projected to positively influence the market growth. Moreover, rising prominence of lifestyle diseases, such as diabetes, and hypertension, is anticipated to elevate the number of people suffering from piles. According to another data by the WHO, over 422 million people around the globe suffer from diabetes, and it causes about 1.6 million deaths every year. On account of these factors, the demand for hemorrhoid drugs is anticipated to increase over the forecast period. 


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3057
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Hemorrhoid Drugs Market size is likely to expand at significant growth rate during the forecast period i.e., between 2025-2037.

Growing prevalence of piles or hemorrhoids on the back of poor diet, lifestyle diseases and obesity, will propel the market growth.

Europe industry is likely to account for largest revenue share by 2037, on the back of high geriatric population, coupled with availability of advanced treatment options, better reimbursement policies and fast commercialization of novel products.

The major players in the market are Taro Pharmaceutical Industries Ltd., AstraZeneca, The Himalaya Drug Company, Panacea Biotec Ltd., Abbott Healthcare Private Limited, Sanofi-aventis Groupe, Pfizer Inc., Purdue Pharma L.P and others.

Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample